SCHEMBL8337443

SCHEMBL8337443

O=Cc1cnc(-c2ccco2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.44
KDM4E B2RXH2 8/20 0.41
POLB P06746 4/20 0.41
RECQL P46063 3/20 0.41
ESR2 Q92731 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
NR4A1 P22736 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
HSD17B10 Q99714 3/20 0.38
ALOX15 P16050 2/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TSHR P16473 1/20 0.38
TP53 P04637 1/20 0.38
GLA P06280 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099921 0.75 ALDH1A1 (0.48) ALDH1A1KDM4ETDP1MAPT
SCHEMBL7121403 0.75 ALDH1A1 (0.49) ALDH1A1KDM4EPOLBRECQLESR2
SCHEMBL17742753 0.74 KDM4E (0.49) ALDH1A1KDM4EPOLBRECQLESR2
SCHEMBL21823795 0.74 ALDH1A1 (0.47) ALDH1A1KDM4EPOLBRECQLESR2
SCHEMBL24610008 0.72 TSHR (0.39) ALDH1A1KDM4EPOLBTDP1HSD17B10
SCHEMBL9394 0.72 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL17777362 0.71 KDM4E (0.46) ALDH1A1KDM4EPOLBRECQLESR2
SCHEMBL17742740 0.71 ALDH1A1 (0.54) ALDH1A1KDM4EPOLBRECQLTDP1
SCHEMBL15082786 0.70 DPP4 (0.47) ALDH1A1KDM4EPOLBRECQLTDP1
SCHEMBL17773144 0.70 KDM4E (0.45) ALDH1A1KDM4EPOLBRECQLESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4272270-B1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES HELIATEK GMBH (DE) 2026-03-18 EP disclosed
US-20240109878-A1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES HELIATEK GMBH (DE) 2024-04-04 US disclosed
EP-4272270-A1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES Heliatek GmbH (DE) 2023-11-08 EP disclosed
WO-2022144429-A1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES HELIATEK GMBH (DE) 2022-07-07 WO disclosed
WO-2022144429-A1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES HELIATEK GMBH (DE) 2022-07-07 WO disclosed
WO-2004058254-A1 HETEROARYLALKANOIC ACIDS AS INTEGRIN RECEPTOR ANTAGONISTS PHARMACIA CORPORATION (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240109878-A1 COMPOUND AND ITS USE IN ORGANIC ELECTRONIC DEVICES XPA, EED, SUN2 ALDH1A1 3499/4885KDM4E 204/4885POLB 2249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.